myBRCA

A simple screening test to help you understand your risk for hereditary breast and ovarian cancer.

Why should you get screened?

The BRCA genes (BRCA1 and BRCA2) are part of your body’s natural defense system. They protect you from developing certain cancers.

If you have a BRCA gene that is not working properly (meaning, it carries a harmful mutation), your lifetime risk of developing breast, ovarian and other cancers increases significantly.1,2

BRCA mutations can significantly increase your lifetime risk of developing breast and/or ovarian cancer.1,2

A BRCA mutation can increase the lifetime risk of breast cancer in women from 12% to 80% by age 80.3

12%

general population risk

80%

with a BRCA mutation

A BRCA mutation can increase the lifetime risk of ovarian cancer in women from 1.3% to 40% by age 80.3

1.3%

general population risk

40%

with a BRCA mutation

The myBRCA screening test will:

  • Help you understand your risk for developing hereditary breast and/or ovarian cancer
  • Improve your odds of early detection and prevention
  • Help identify other potential at-risk family members

How to get started

1

Order the test

Contact the distributor at the bottom of this page

2

Collect your sample

Physician or lab personnel collect your sample

3

Sample is processed

Your sample gets processed at VeritasGenetics’ CLIA lab

4

Your report is ready

VeritasGenetics interprets your results and provides a report to your physician

Possible outcomes

  • Any result, negative, positive, or inconclusive, should become a part of how you and your doctor evaluate your health and clinical needs.
  • You can watch this pre-test video or download this written summary for an explanation of how myBRCA testing works and what your potential outcomes could mean.

Technical information

  • Next generation sequencing (NGS) on the Illumina advanced platform
  • Clinically validated based on CDC, CAP, CLIA, ACMG and CLSI guidelines
  • Analytical sensitivity and specificity of over 99.99%
  • Additional deletion/duplication assay included
  • Multi-ethnic validation (27.7% of validation samples were from non-white donors including persons of American, Hispanic, African-East Asian, and Middle Eastern ancestry)
  • Results interpreted by a physician trained in genetics with over 10 years of experience with NGS

Contact

Phone: 1234-123-123-4

Address: XYZ Distributor Address

E-mail: 1234-123-123-4

About VeritasGenetics

VeritasGenetics is a global pioneer in disease prevention through accessible genetic information. By removing the barriers to genetic screening, Veritas empowers individuals and doctors to make informed lifestyle decisions that can lead to disease prevention and longer and healthier lives. Veritas is founded by leaders in genomics from Harvard Medical School and operates globally from its offices in the U.S., Europe and China.

  1. National Cancer Institute. BRCA1 & BRCA2: Cancer Risk & Genetic Testing. 2015. NCI
  2. American Cancer Society. Breast cancer risk factors you cannot change. 2015. ACS
  3. Petrucelli N, Daly MB, Feldman GL. BRCA1 and BRCA2 Hereditary Breast and Ovarian Cancer. 1998 Sep 4 [Updated 2013 Sep 26]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2015. Available from: NCBI